SPC2996

Santaris Pharma A/S · Phase 1 active Small molecule

At a glance

Generic name	SPC2996
Sponsor	Santaris Pharma A/S
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

SPC2996 in Chronic Lymphocytic Leukaemia (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SPC2996 CI brief — competitive landscape report
SPC2996 updates RSS · CI watch RSS
Santaris Pharma A/S portfolio CI